Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Saccharomyces cerevisiae | Rtt109p | Starlite/ChEMBL | References |
Homo sapiens | monoglyceride lipase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | esterase, putative | monoglyceride lipase | 303 aa | 254 aa | 19.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 0.466 | 1 |
Schistosoma mansoni | CREB-binding protein 2 | 0.0111 | 0.655 | 0.655 |
Plasmodium falciparum | lysophospholipase, putative | 0.0084 | 0.466 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 0.466 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0084 | 0.466 | 1 |
Echinococcus multilocularis | CREB binding protein | 0.0111 | 0.655 | 0.655 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0084 | 0.466 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 0.466 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0149 | 0.9203 | 0.9203 |
Mycobacterium ulcerans | lysophospholipase | 0.0084 | 0.466 | 0.5 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.0084 | 0.466 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.1417 | 0.1417 |
Plasmodium falciparum | lysophospholipase, putative | 0.0084 | 0.466 | 1 |
Echinococcus granulosus | muscleblind protein | 0.0149 | 0.9203 | 0.9502 |
Leishmania major | monoglyceride lipase, putative | 0.0084 | 0.466 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0055 | 0.2638 | 0.2638 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0084 | 0.466 | 1 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0084 | 0.466 | 0.5 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0047 | 0.2079 | 0.5 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0047 | 0.2079 | 0.2146 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.1417 | 0.1417 |
Echinococcus multilocularis | muscleblind protein | 0.0149 | 0.9203 | 0.9203 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0055 | 0.2638 | 0.2638 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.0084 | 0.466 | 0.5 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0084 | 0.466 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0038 | 0.1417 | 0.1417 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.2638 | 0.2638 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0.466 | 1 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0156 | 0.9685 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0.466 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0149 | 0.9203 | 0.9203 |
Echinococcus granulosus | CREB binding protein | 0.0111 | 0.655 | 0.6763 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0084 | 0.466 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 0.466 | 1 |
Brugia malayi | Muscleblind-like protein | 0.0149 | 0.9203 | 0.9203 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0043 | 0.1804 | 0.5 |
Loa Loa (eye worm) | CBP-B | 0.0111 | 0.655 | 0.655 |
Brugia malayi | TAZ zinc finger family protein | 0.0111 | 0.655 | 0.655 |
Plasmodium falciparum | esterase, putative | 0.0084 | 0.466 | 1 |
Plasmodium vivax | PST-A protein | 0.0084 | 0.466 | 1 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0084 | 0.466 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0084 | 0.466 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 0.466 | 1 |
Schistosoma mansoni | CREB-binding protein 1 (SmCBP1) | 0.0111 | 0.655 | 0.655 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0047 | 0.2079 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0055 | 0.2638 | 0.2638 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0149 | 0.9203 | 0.9203 |
Echinococcus granulosus | CREB binding protein | 0.0111 | 0.655 | 0.6763 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | Inhibition of Vps75-stimulated recombinant Saccharomyces cerevisiae histone acetyltransferase Rtt109 assessed as H3K56 acetylated product at 125 uM after 45 mins by Slot bolt inhibiton assay | ChEMBL. | 25634295 | |
Activity (binding) | Inhibition of Vps75-stimulated recombinant Saccharomyces cerevisiae histone acetyltransferase Rtt109 assessed as H3K27 acetylated product at 125 uM after 45 mins by Slot bolt inhibiton assay | ChEMBL. | 25634295 | |
IC50 (binding) | = 2.39 uM | Displacement of [3H]2-OG from human MGL by liquid scintillation counting | ChEMBL. | 19583260 |
IC50 (binding) | = 6.1 uM | Inhibition of Vps75-stimulated recombinant Saccharomyces cerevisiae histone acetyltransferase Rtt109 using Asf1-dH3-H4 as substrate assessed as coenzyme A production after 45 mins by CPM based HTS assay | ChEMBL. | 25634295 |
IC50 (binding) | = 10 uM | Inhibition of Vps75-stimulated recombinant Saccharomyces cerevisiae histone acetyltransferase Rtt109 using Asf1-dH3-H4 as substrate assessed as coenzyme A production after 45 mins by CoA-based HTS counter screen assay | ChEMBL. | 25634295 |
IC50 (binding) | = 89 uM | Displacement of [3H]ethanolamine from human recombinant FAAH by liquid scintillation counting | ChEMBL. | 19583260 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.